ZVIA — what changed in the latest 10-Q
A section-by-section comparison of ZVIA's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-05 vs the prior 10-Q · 2026-05-06
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +24 | −11 | ~20 | 49 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~3 | 6 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Some risk factors updated | 0 | −4 | ~1 | 0 |
| Other information | Text added/removed | +3 | 0 | ~1 | 11 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-05
In June 2026, the Board of Directors appointed current director, Alexandre I. Ruberti to succeed Amy Taylor as the Company's President and Chief Executive Officer.
Our selling expenses are expected to increase in the short-term due to higher freight costs driven by increased fuel rates, which have been affected by the ongoing conflicts in the Middle East. Over time, we expect selling expenses to decrease as a percentage of net sales as a result of our Producti…
During the three months ended June 30, 2026, we recognized $1.0 million of equity-based compensation expense related to awards granted in connection with endorsement agreement with Cardi B. Excluding the impact of non-employee grants, our equity-based compensation expense is expected to remain relat…
Net sales were $45.0 million for the three months ended June 30, 2026 as compared to $44.5 million for the three months ended June 30, 2025. Equivalized cases sold were 3.4 million during the three months ended June 30, 2026 as compared to 3.5 million during the three months ended June 30, 2025. The…
Cost of goods sold was $23.0 million for the three months ended June 30, 2026 as compared to $22.8 million for the three months ended June 30, 2025. The increase of $0.1 million, or 0.6%, was largely due to unfavorable unit costs of $1.0 million driven by aluminum tariffs. This increase was partiall…
Text removed vs the prior filing · source: 10-Q · 2026-05-06
We increased our spend on promotional activity at key accounts, returning back to historical promotion levels, in order to drive velocity, which we expect to continue throughout 2026.
Our selling expenses are expected to increase in the short-term due to the effect of the ongoing conflicts in the Middle East. Excluding the effect of conflicts in the Middle East, our selling expenses are expected to decrease as a percentage of sales over time as a result of our Productivity Initia…
Net sales were $46.1 million for the three months ended March 31, 2026 as compared to $38.0 million for the three months ended March 31, 2025. Equivalized cases sold were 3.6 million during the three months ended March 31, 2026 as compared to 3.0 million during the three months ended March 31, 2025.…
Cost of goods sold was $23.8 million for the three months ended March 31, 2026 as compared to $19.0 million for the three months ended March 31, 2025. The increase of $4.8 million, or 25.3%, was largely due to increased volumes which resulted in $3.9 million of higher costs of goods sold, unfavorabl…
Gross profit was $22.3 million for the three months ended March 31, 2026 as compared to $19.0 million for the three months ended March 31, 2025. The increase in gross profit of $3.3 million, or 17.1%, was primarily due to higher volumes and lower spend on promotional activity, partially offset by un…
Risk factors
Text removed vs the prior filing · source: 10-Q · 2026-05-06
Disruptions in the worldwide economy, including changes to trade policies, may adversely affect our business, results of operations and financial condition.
Adverse and uncertain economic conditions, including the impacts of inflation, changes in trade policies, and governmental tariffs, may impact distributor, retailer and consumer demand for our products. For example, on March 12, 2025, the U.S. government imposed a 25% tariff on all steel and aluminu…
Any resulting economic downturn or increase in geopolitical tensions may adversely impact consumers’ discretionary income and/or adversely affect consumer purchasing behavior, which could have a material adverse effect on our results of operations and financial condition. The uncertainty resulting f…
The imposition or threat of tariffs or additional sanctions on imports or exports in the U.S., Canada or jurisdictions from which we source our supplies could have an adverse impact on our supply chain, results of operations, or overall business. Additionally, the recent implementation of an import …
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-05
First Amendment to Loan and Security Agreement dated May 15, 2026 by and among Zevia PBC, as borrower, the lenders party thereto and Bank of America, N.A., as agent.
Offer Letter dated June 10, 2026 between Zevia PBC and Alexandre Ruberti.
Severance Agreement dated June 15, 2026 between Zevia PBC and Alexandre Ruberti.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice